Legend Bio CEO resigns, shares tumble
Drugmaker Legend Biotech Corp. (LEGN.US) said on Monday that Huang Ying resigned as the company’s CEO and member of its board effective July 24, without giving any reason for his departure.…
Biokin’s world-first bispecific ADC hits milestones, speeding commercialization
Iza-bren was approved for recurrent or metastatic esophageal squamous cell carcinoma, after receiving earlier approval to treat nasopharyngeal carcinoma Key Takeaways: New approvals for Biokin’s Iza-bren highlight the rise of…
Tong Ren Tang Healthcare makes trading debut, backed by 39% annual patient growth
The company will use a majority of the $68 million it raised from its Hong Kong listing to expand its network of traditional Chinese medicine hospitals and clinics Key Takeaways:…
Shaanxi Micot shares nearly double in Hong Kong trading debut
Shares of drugmaker Shaanxi Micot Pharmaceutical Technology Co. Ltd. (2335.HK) jumped in their Hong Kong trading debut on Wednesday, after the company raised HK$989 million ($126 million) by selling about…
Seer Tech posts modest gain in Hong Kong trading debut
Shares of robot control systems provider Shanghai Seer Intelligent Technology Co. Ltd. (6106.HK) opened flat in their Hong Kong trading debut on Wednesday, then edged higher during the morning to…
BRIEF: Star Sports Medicine launches $97 million Hong Kong IPO
Medical device maker Star Sports Medicine Co. Ltd. (1609.HK) on Friday launched its Hong Kong IPO, aiming to raise HK$758 million ($96.8 million) by selling 8.4 million shares for HK$98.50…
Tong Ren Tang kicks off IPO leveraging time-honored medicinal brand to offer healthcare
One of China’s oldest medical names has applied to list its Tong Ren Tang Healthcare Investment unit, which is building an integrated healthcare system Key Takeaways: Top-rated non-public traditional Chinese…
Recent Articles
RELATED ARTICLES
-
BRIEF: Legend Biotech’s revenue jumps on growing momentum for cancer treatment
- BRIEF: Legend Biotech posts strong fourth-quarter revenue gain
- CEO of Anta’s namesake brand resigns on weak performance
- Time for a new song? Jay Chou-powered Star Plus Legend sings the blues
- Topsport sales sag in latest fiscal quarter, as its shares tumble on Nike reports
- Mega licensing deal lifts 3SBio profits but core sales slip
- BRIEF: CANbridge raises $26 million in share sale to WuXi Bio at 14.7% discount
